Brief: Cereno Scientific Obtains First Patent For Drug Candidate HDAC Inhibitor CS014

Cereno Scientific AB

17/01/2024 14:18

Jan 17 (Reuters) - Cereno Scientific AB  CRNOSb.ST :
    * CERENO SCIENTIFIC OBTAINS FIRST PATENT FOR DRUG CANDIDATE HDAC INHIBITOR CS014 IN
DEVELOPMENT
FOR THROMBOSIS PREVENTION TREATMENT
    * DRUG CANDIDATE CS014, A NOVEL HDAC INHIBITOR, HAS OBTAINED AN ISSUED PATENT IN UK.

Source text for Eikon:  ID:nWkr7c777z 
Further company coverage:  CRNOSb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))